Odyssey Health (ODYY) EBIT Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) EBIT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 13.06% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | 35.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 35.22% |
| Jan 31, 2026 | 50.35% |
| Oct 31, 2025 | 47.35% |
| Jul 31, 2025 | 56.06% |
| Apr 30, 2025 | 64.43% |
| Jan 31, 2025 | 57.05% |
| Oct 31, 2024 | 25.99% |
| Jul 31, 2024 | 27.88% |
| Apr 30, 2024 | 68.66% |
| Jan 31, 2024 | -22.23% |
| Oct 31, 2023 | 12.89% |
| Jul 31, 2023 | 17.26% |
| Apr 30, 2023 | -8.05% |
| Jan 31, 2023 | -43.81% |
| Oct 31, 2022 | -16.25% |
| Jul 31, 2022 | 57.19% |
| Apr 30, 2022 | -298.82% |
| Jan 31, 2022 | -180.26% |
| Oct 31, 2021 | -201.02% |
| Jul 31, 2021 | -217.08% |